Clinical Study Results Sanofi Pharma, including Sanofi Genzyme

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter N

Generic Name Trade Name Condition Study Code Study Name ACCESS TO STUDY / PROTOCOL Access to results
NERISPIRDINE Not marketed Multiple Sclerosis ACT10573 NA NCT00772525
NERISPIRDINE Not Marketed Multiple Sclerosis DRI10566 NA EudraCT: 2008-001999-67
NOVEL INSULIN Not Marketed Diabetes Mellitus, Type 1 TDU10948 NA NCT01053728
NOVEL INSULIN Not Marketed Diabetes Mellitus, Type 1 TDU10987 NA NCT01053728

*These study results were previously posted on
**This link replaces the same summary that was previously posted